http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2012203061-B2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a1cb79011635aece4870341b7bdd0469 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-353 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-498 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-33 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-337 |
filingDate | 2012-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2013-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf1a7c3c2a195d130b037bbf70ecc506 |
publicationDate | 2013-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | AU-2012203061-B2 |
titleOfInvention | Compounds, composition, methods, targets for cancer therapy |
abstract | This invention describes methods and pharmaceutical compositions for combinational cancer treatments that are capable of blocking cancer cell trans-plasma membrane electron transfer and respiration in combination with inhibiting cancer cell hypoxia responses to induce cell death. It also 5 identified genes as target for anti-cancer drug development and enhancement of the chemotherapeutic drug effect for the treatment of cancer. This invention points to a novel method and principle for a new avenue of developing more efficient and low or non-cytotoxic cancer treatment. |
priorityDate | 2007-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 577.